Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 138,524 shares at $13.00 ($1.8M) on 2018-05-21, disclosed to the SEC on 2018-05-23.
Open-market sale of $1.8M CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.14 | 17,798 | $216K | 12.2% |
| 2 | $12.14 | 17,798 | $216K | 12.2% |
| 3 | $13.00 | 16,140 | $210K | 11.8% |
| 4 | $13.00 | 30,932 | $402K | 22.7% |
| 5 | $13.01 | 27,928 | $363K | 20.5% |
| 6 | $13.01 | 27,928 |
| $363K |
| 20.5% |
| Total | $12.78 avg | 138,524 | $1.8M | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |